Measuring Quality of Life

  • M. A. List
  • L. Liu


Twenty-five years ago, when one spoke of outcomes in cancer treatment, it was assumed that the reference was to endpoints of tumor response, survival, and/or disease-free survival. Over the past 2 decades, however, with the introduction of multimodality treatments and the increasing number of cancer survivors, has come the growing awareness of, and concern for, the psychosocial needs of cancer patients. The loss of health and/or the consequences of treatment may result in physical or functional impairment, disruption of social and family interactions, and psychological distress, all of which affect quality of life (QOL). Accordingly, health care interventions must be judged on the basis of their effect upon quality as well as quantity of life. Extending survival does not always correlate with improvements in quality and, conversely, a treatment may not prolong life but may profoundly alter it. Understanding a patient’s experience of his/her disease, its treatment, and symptoms is thus critical to comprehensive cancer care and evaluation of therapeutic options.


Comprehensive Cancer Care Scale Nottingham Health Profile Zealand Breast Cancer Trial Group Breast Cancer Chemotherapy Questionnaire 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Holland J (1991) Progress and challenges in psychosocial and behavioral research in cancer in the twentieth century. Cancer 67:767–773PubMedCrossRefGoogle Scholar
  2. 2.
    Cella DF, Tulsky DS (1993) Quality of life in cancer: definition, purpose and method of measurement. Cancer Invest 11:327–336PubMedCrossRefGoogle Scholar
  3. 3.
    Gotay CC (1996) Trial-related quality of life: using qualityof-life assessments to distinguish among cancer therapies. J Natl Cancer Inst Monogr 20:1–6PubMedGoogle Scholar
  4. 4.
    Celia D (2001) Research methods in psycho-oncology: quality of life. In: Holland JC, Jacobson PB, McCorkle R et al (eds) Psycho-oncology. Oxford University Press, New YorkGoogle Scholar
  5. 5.
    Moinpur CM, Feigl P, Metch B et al (1989) Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 81:475–495Google Scholar
  6. 6.
    Ware JE, Kosinski MA, Bayliss MS et al (1995) Comparison of methods for scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33:AS264–AS279PubMedCrossRefGoogle Scholar
  7. 7.
    Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12:608–616PubMedGoogle Scholar
  8. 8.
    List MA, Mumby P, Haraf D et al (1997) Performance and quality of life outcomes in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6:274–284PubMedCrossRefGoogle Scholar
  9. 9.
    Lindley CM, Hirsch JD, O’Neill CV et al (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1:331–340PubMedCrossRefGoogle Scholar
  10. 10.
    Sugarbaker PH, Barofsky I, Rosenberg SA et al (1982) Quality of life assessment of patients in extremity sarcoma trials. Surgery 91:17–23PubMedGoogle Scholar
  11. 11.
    Coates A, Gebski V, Bishop JF et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 317:1490–1495PubMedCrossRefGoogle Scholar
  12. 12.
    Kornblith AB, Holland JC (1994) Handbook of measures for psychological, social and physical function in cancer, vol 1. Quality of life. Memorial Sloan-Kettering Cancer Center, New YorkGoogle Scholar
  13. 13.
    Spilker B (ed) (1996) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, PhiladelphiaGoogle Scholar
  14. 14.
    Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMedCrossRefGoogle Scholar
  15. 15.
    Dancey J (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. Qual Life Res 6:151–158PubMedCrossRefGoogle Scholar
  16. 16.
    Hammerlid E, Taft C (2001) Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84:149–156.PubMedCrossRefGoogle Scholar
  17. 17.
    Seymour MT, Slevin ML, Kerr DJ et al (1996) Randomized trial assessing the addition of interferon α-2a to fluorouracil and leucovorin in advanced colorectal cancer. J Clin Oncol 14:2280–2288PubMedGoogle Scholar
  18. 18.
    Coates A, Forbes J, Simes RJ (1993) Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group (letter). J Clin Oncol 11:2050PubMedGoogle Scholar
  19. 19.
    Burris HA (1996) Objective outcome measures of quality of life. Oncology Huntingt 10[Suppl 11]:131–135PubMedGoogle Scholar
  20. 20.
    Weeks J (1996) Taking quality of life into account in health economic analyses. J Natl Cancer Inst Monogr 20:23–28PubMedGoogle Scholar
  21. 21.
    Till JE (1996) Uses (and possible abuses) of quality-of-life measures. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, PhiladelphiaGoogle Scholar
  22. 22.
    Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139–144PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • M. A. List
  • L. Liu

There are no affiliations available

Personalised recommendations